Ajax-Loading

Eli Lilly and Company - Funds From Operation To Total Debt

Eli Lilly and Company's Fiscal Year is From January To December - All Figures are in Percent.

The item "Funds-From-Operation-To-Total-Debt" stands at 37.79 percent as of 09/30/2025, the highest value since 03/31/2023.

As of the end of Eli Lilly and Company's third quarter, the item "Funds From Operation To Total Debt" stands at 37.79 Percent. This represents an increase of 10.38 percentage points compared to it's value at the end of it's second quarter .


Regarding the One-Year-Change of the series, the current value constitutes an increase of 18.40 percentage points compared to the value the year prior.
The 1 year change in percentage points is 18.40.
The 3 year change in percentage points is -13.06.

The Serie's long term average value is 31.38 percent. It's latest available value, on 09/30/2025, is 6.41 percentage points higher, compared to it's long term average value.
The Serie's change in percentage points from it's minimum value, on 03/31/2024, to it's latest available value, on 09/30/2025, is +23.77.
The Serie's change in percentage points from it's maximum value, on 09/30/2022, to it's latest available value, on 09/30/2025, is -13.06.

Funds From Operation To Total Debt for Related Companies:

LogoNameMarket Cap (USD)
LogoJohnson & Johnson - Funds From Operation To Total Debt486,508,953,600.00
LogoAbbVie Inc - Funds From Operation To Total Debt399,570,305,024.00
LogoRoche Holding AG - Funds From Operation To Total Debt317,433,206,677.55
LogoAstraZeneca PLC - Funds From Operation To Total Debt280,205,508,085.11
LogoNovartis AG - Funds From Operation To Total Debt255,096,620,580.91